Skip to content

Nomogram construction and validation for predicting infection recurrence after necrotic tissue debridement in severe acute pancreatitis

Nomogram construction and validation for predicting infection recurrence after necrotic tissue debridement in severe acute pancreatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126981
Enrollment
Unknown
Registered
2026-06-22
Start date
2026-06-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with acute severe pancreatitis after necrotic tissue debridement

Interventions

Validation group (Postoperative infection recurrence within 30 days):None
Modeling group (Postoperative infection recurrence within 30 days):None

Sponsors

First Affiliated Hospital of Kunming Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for SAP as outlined in the "Chinese Guidelines for the Diagnosis and Treatment of Acute Pancreatitis (2021)"; 2. Underwent pancreatic necrosectomy; 3. Preoperative infection was clinically controlled after treatment, meeting the conditions for observing postoperative infection recurrence; 4. Possess complete clinical data and surgical records; 5. Postoperative follow-up of at least 3 months.

Exclusion criteria

Exclusion criteria: 1. Diffuse abdominal infection or infectious complications requiring emergency preoperative surgery; 2. Immunodeficiency diseases or long-term use of immunosuppressants; 3. Malignant tumors; 4. Death during surgery or within 48 hours postoperatively.

Design outcomes

Primary

MeasureTime frame
Postoperative infection recurrence within 30 days;

Secondary

MeasureTime frame
APACHE II Score;CTSI Score;

Countries

China

Contacts

Public ContactZiyun Yang

First Affiliated Hospital of Kunming Medical University

1031555371@qq.com+86 871 65324888

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 3, 2026